Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion type Assertion NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_head.
- NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion description "[If p53 mutations develop frequently in relapsed neuroblastoma, cytotoxic agents more sensitive to mutant p53 might be more effective at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_provenance.
- NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion evidence source_evidence_literature NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_provenance.
- NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion SIO_000772 11196202 NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_provenance.
- NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion wasDerivedFrom befree-20150227 NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_provenance.
- NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_assertion wasGeneratedBy ECO_0000203 NP752463.RAGgtqx9wSklrm66JmLw5nUl9jFSGH5ps0kFsB4Kmo8Qs130_provenance.